Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer’s disease (BLAZE)

被引：0

作者：

Stephen Salloway

Lee A. Honigberg

William Cho

Michael Ward

Michel Friesenhahn

Flavia Brunstein

Angelica Quartino

David Clayton

Deborah Mortensen

Tobias Bittner

Carole Ho

Christina Rabe

Stephen P. Schauer

Kristin R. Wildsmith

Reina N. Fuji

Shehnaaz Suliman

Eric M. Reiman

Kewei Chen

Robert Paul

机构：

[1] The Warren Alpert Medical School of Brown University,Department of Neurology and Psychiatry

[2] Genentech Inc.,undefined

[3] F Hoffmann-La Roche Ltd.,undefined

[4] Banner Alzheimer’s Institute,undefined

来源：

Alzheimer's Research & Therapy | / 10卷

关键词：

Alzheimer’s disease; Biomarkers; Positron emission tomography; Monoclonal antibodies; Antibodies; Humanized;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 168 条